Less can be more at the end of life

20:00 EDT 15 May 2018 | AAAS

(Queensland University of Technology) Advances in medicine mean health care professionals can prolong life, yet some treatments have a low chance of providing tangible benefits to some patients, can result in a 'bad death' and represent a multi-million dollar cost to the public purse. A QUT-led collaboration between health and law researchers has just received $500,000 funding from the NHMRC to examine the issue and improve end-of-life care.

Original Article: Less can be more at the end of life


More From BioPortfolio on "Less can be more at the end of life"

Quick Search


Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...